Investigation of 90Y-avidin for prostate cancer brachytherapy: a dosimetric model for a phase I-II clinical study.
about
An analytical model for calculating internal dose conversion coefficients for non-human biota.After low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancerDesign and solid phase synthesis of new DOTA conjugated (+)-biotin dimers planned to develop molecular weight-tuned avidin oligomers.Interventional nuclear medicine.
P2860
Investigation of 90Y-avidin for prostate cancer brachytherapy: a dosimetric model for a phase I-II clinical study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Investigation of 90Y-avidin fo ...... r a phase I-II clinical study.
@en
Investigation of 90Y-avidin fo ...... r a phase I-II clinical study.
@nl
type
label
Investigation of 90Y-avidin fo ...... r a phase I-II clinical study.
@en
Investigation of 90Y-avidin fo ...... r a phase I-II clinical study.
@nl
prefLabel
Investigation of 90Y-avidin fo ...... r a phase I-II clinical study.
@en
Investigation of 90Y-avidin fo ...... r a phase I-II clinical study.
@nl
P2093
P2860
P1476
Investigation of 90Y-avidin fo ...... or a phase I-II clinical study
@en
P2093
Andrea Vavassori
Anna Sarnelli
Francesca Botta
Francesco Guerriero
Guido Pedroli
Mahila E Ferrari
Marta Cremonesi
Stefano Severi
P2860
P2888
P304
P356
10.1007/S00259-013-2383-1
P577
2013-05-03T00:00:00Z